They have a lot of benefits beyond their original intention of treating obesity in people with type 2 diabetes, for people who have a lot, or only a little, weight to lose
However, no standardized HCV genotype/subtype determination assay based on deep sequencing was available thus far, making this technology unavailable for clinical studies and clinical practice
In experimental models, MT1 is investigated for its ability to stimulate cyclic AMP (cAMP) production and to activate protein kinase A (PKA)-related pathways, which are involved in melanin production and cellular responses to UV-induced stress
#Endocrinology #Obesity #Diabetes #GLP1 #DrugDiscovery #MASH #MetabolicHealth To view or add a comment, sign in 2,312 followers More from this author TDP-43 Proteinopathy: The Unifying Driver of Neurodegeneration and the Race for a Blood Biomarker NeuroDex 1w ELLA Glial Fibrillary Acidic Protein (GFAP) Immunoassay
For instance, the scope of GLP-1s is expanding: Zepbound by Eli Lilly was recently approved by the FDA for treatment of sleep apnea in patients with obesity, while Ozempic was greenlit to reduce risk for kidney disease and other conditions
Before anybody in the legislature wants to introduce a bill that has to do with compounding